Xiaofen Li

8PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 02, 2026
Impact of adding recurrence/metastasis-directed therapy to systemic therapy in postoperative recurrent or metastatic pancreatic adenocarcinoma: a retrospective cohort study.

Chenyan Zhang, Ruizhen Li, Jun Ji

|Apr 17, 2024
Surufatinib combined with transarterial embolization versus surufatinib monotherapy in patients with liver metastatic neuroendocrine tumors: Study protocol for a prospective, randomized, controlled trial.

Ruizhen Li, Xiaofen Li, Xin You

|Jan 11, 2024
Prediction of Chemotherapy Efficacy in Patients with Colorectal Cancer Ovarian Metastases: A Preliminary Study Using Contrast-Enhanced Computed-Tomography-Based Radiomics.

Jinghan Yu, Xiaofen Li, Hanjiang Zeng

|Mar 30, 2022
Neoadjuvant treatment of sintilimab plus hypofractionated radiotherapy for MSI-H/dMMR rectal cancer: A prospective, multicenter, phase Ib study.

Xiaofen Li, Chao Fang, Xin Wang

|Jul 08, 2021
The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer.

Xiao-Li Wei, Qian-Wen Liu, Fu-Rong Liu

|Apr 29, 2021
Olaparib Treatment in a Patient with Advanced Gallbladder Cancer Harboring BRCA1 Mutation.

Xiaofen Li, Limin Gao, Meng Qiu

Pageof 2

Frequent Collaborators

1 joint publications

Meng Qiu

1 joint publications

Ziqiang Wang

1 joint publications

Hongkun Yin

1 joint publications

Ruizhen Li